GRIK3
Glutamate receptor ionotropic, kainate 3
Also known as: GluK3, GLUR7, GRIK3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q13003
- Gene
- GRIK3
- Ensembl
- ENSG00000163873
- Chromosome
- 1
- Canonical length
- 919 aa
- Protein class
- FDA approved drug targets, Plasma proteins, Predicted membrane proteins
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
Glutamate receptors are the predominant excitatory neurotransmitter receptors in the mammalian brain and are activated in a variety of normal neurophysiologic processes. This gene product belongs to the kainate family of glutamate receptors, which are composed of four subunits and function as ligand-activated ion channels. It is not certain if the subunit encoded by this gene is subject to RNA editing as the other 2 family members (GRIK1 and GRIK2). A Ser310Ala polymorphism has been associated with schizophrenia, and there are conflicting reports of its association with the pathogenesis of delirium tremens in alcoholics. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
919 residues, UniProt reviewed canonical sequence.
>Q13003|GRIK3
1 MTAPWRRLRS LVWEYWAGLL VCAFWIPDSR GMPHVIRIGG IFEYADGPNA QVMNAEEHAF
61 RFSANIINRN RTLLPNTTLT YDIQRIHFHD SFEATKKACD QLALGVVAIF GPSQGSCTNA
121 VQSICNALEV PHIQLRWKHH PLDNKDTFYV NLYPDYASLS HAILDLVQYL KWRSATVVYD
181 DSTGLIRLQE LIMAPSRYNI RLKIRQLPID SDDSRPLLKE MKRGREFRII FDCSHTMAAQ
241 ILKQAMAMGM MTEYYHFIFT TLDLYALDLE PYRYSGVNLT GFRILNVDNP HVSAIVEKWS
301 MERLQAAPRS ESGLLDGVMM TDAALLYDAV HIVSVCYQRA PQMTVNSLQC HRHKAWRFGG
361 RFMNFIKEAQ WEGLTGRIVF NKTSGLRTDF DLDIISLKED GLEKVGVWSP ADGLNITEVA
421 KGRGPNVTDS LTNRSLIVTT VLEEPFVMFR KSDRTLYGND RFEGYCIDLL KELAHILGFS
481 YEIRLVEDGK YGAQDDKGQW NGMVKELIDH KADLAVAPLT ITHVREKAID FSKPFMTLGV
541 SILYRKPNGT NPSVFSFLNP LSPDIWMYVL LAYLGVSCVL FVIARFSPYE WYDAHPCNPG
601 SEVVENNFTL LNSFWFGMGS LMQQGSELMP KALSTRIIGG IWWFFTLIII SSYTANLAAF
661 LTVERMESPI DSADDLAKQT KIEYGAVKDG ATMTFFKKSK ISTFEKMWAF MSSKPSALVK
721 NNEEGIQRAL TADYALLMES TTIEYVTQRN CNLTQIGGLI DSKGYGIGTP MGSPYRDKIT
781 IAILQLQEED KLHIMKEKWW RGSGCPEEEN KEASALGIQK IGGIFIVLAA GLVLSVLVAV
841 GEFVYKLRKT AEREQRSFCS TVADEIRFSL TCQRRVKHKP QPPMMVKTDA VINMHTFNDR
901 RLPGKDSMAC STSLAPVFPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GRIK3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 3
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 11 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 11 nTPM
- pituitary gland: 8.6 nTPM
- colon: 7.4 nTPM
- hypothalamus: 6.9 nTPM
- midbrain: 6.1 nTPM
- retina: 4.1 nTPM
Single-cell type
- pituicytes/fscs: 842 nCPM
- oligodendrocyte progenitor cells: 132 nCPM
- müller glia: 125 nCPM
- schwann cells: 123 nCPM
- brain inhibitory neurons: 87 nCPM
- bergmann glia: 58 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- pons: 47 nTPM
- basal ganglia: 36 nTPM
- medulla oblongata: 34 nTPM
- cerebral cortex: 34 nTPM
- hypothalamus: 32 nTPM
- midbrain: 31 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GRIK3.
Disease | ImmuneIEDB
Conditions an epitope on GRIK3 was assayed in.
- glioblastoma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.19
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.01
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- G protein-coupled glutamate receptor signaling pathway
- glutamate receptor signaling pathway
- modulation of chemical synaptic transmission
- negative regulation of synaptic transmission, glutamatergic
- regulation of membrane potential
- synaptic transmission, glutamatergic
Molecular functions
- adenylate cyclase inhibiting G protein-coupled glutamate receptor activity
- glutamate receptor activity
- glutamate-gated calcium ion channel activity
- glutamate-gated receptor activity
- kainate selective glutamate receptor activity
- ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential
- transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Ionotropic glutamate receptor, C-terminal
- Ionotropic glutamate receptor, metazoa
- Receptor, ligand binding region
- Ionotropic glutamate receptor
- Ionotropic glutamate receptor, L-glutamate and glycine-binding domain
- Periplasmic binding protein-like I
- Ligand-gated ion channel
- Receptor family ligand binding region
- Ligated ion channel L-glutamate- and glycine-binding site
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GRIK3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
- NETO2
- PRKCABP
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GRIK3 as an antibody target. Whether an autoantibody or antibody against GRIK3 could matter depends on whether native GRIK3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GRIK3 is annotated at the cell surface, where native GRIK3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label GRIK3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...